LUMINOS-101: Phase 2 study of PVSRIPO with pembrolizumab in recurrent glioblastoma.
Publication
, Conference
Kelly, AT; Ambady, P; Brown, M; Butowski, N; Cavaliere, R; Curry, W; Desjardins, A; Franklin, L; Friedman, H; Gromeier, M; Jackson, L; Ong, S ...
Published in: CANCER RESEARCH
2021
Duke Scholars
Published In
CANCER RESEARCH
EISSN
1538-7445
ISSN
0008-5472
Publication Date
2021
Volume
81
Issue
13
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3101 Biochemistry and cell biology
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Kelly, A. T., Ambady, P., Brown, M., Butowski, N., Cavaliere, R., Curry, W., … Nichols., G. (2021). LUMINOS-101: Phase 2 study of PVSRIPO with pembrolizumab in recurrent glioblastoma. In CANCER RESEARCH (Vol. 81).
Kelly, Andrea True, Prakash Ambady, Michael Brown, Nicholas Butowski, Robert Cavaliere, William Curry, Annick Desjardins, et al. “LUMINOS-101: Phase 2 study of PVSRIPO with pembrolizumab in recurrent glioblastoma.” In CANCER RESEARCH, Vol. 81, 2021.
Kelly AT, Ambady P, Brown M, Butowski N, Cavaliere R, Curry W, et al. LUMINOS-101: Phase 2 study of PVSRIPO with pembrolizumab in recurrent glioblastoma. In: CANCER RESEARCH. 2021.
Kelly, Andrea True, et al. “LUMINOS-101: Phase 2 study of PVSRIPO with pembrolizumab in recurrent glioblastoma.” CANCER RESEARCH, vol. 81, no. 13, 2021.
Kelly AT, Ambady P, Brown M, Butowski N, Cavaliere R, Curry W, Desjardins A, Franklin L, Friedman H, Gromeier M, Jackson L, Mixson L, Ong S, Randazzo D, Sloan A, Wen P, Nichols. G. LUMINOS-101: Phase 2 study of PVSRIPO with pembrolizumab in recurrent glioblastoma. CANCER RESEARCH. 2021.
Published In
CANCER RESEARCH
EISSN
1538-7445
ISSN
0008-5472
Publication Date
2021
Volume
81
Issue
13
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3101 Biochemistry and cell biology
- 1112 Oncology and Carcinogenesis